Article Information
History
- January 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- M. Taquet, Ph.D., B.M. B.Ch.1,2,
- J.R. Geddes, M.D., F.R.C.Psych.1,2,
- M. Husain, D.Phil., F.R.C.P.3,4,
- S. Luciano, B.A.5 and
- P.J. Harrison, D.M. (Oxon), F.R.C.Psych.1,2,*
- 1Department of Psychiatry, University of Oxford, Oxford, U.K.
- 2Oxford Health NHS Foundation Trust, Oxford, U.K.
- 3Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, U.K.
- 4Oxford University Hospitals NHS Foundation Trust, Oxford, U.K.
- 5TriNetX Inc, Cambridge MA, USA
- ↵*Correspondence: Paul Harrison, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, United Kingdom. paul.harrison{at}psych.ox.ac.uk
Posted January 24, 2021.
Six-month Neurological and Psychiatric Outcomes in 236,379 Survivors of COVID-19
